Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration

Br J Pharmacol. 2001 Jan;132(1):101-10. doi: 10.1038/sj.bjp.0703777.

Abstract

1. The effects of I(Ks) block by chromanol 293B and L-735,821 on rabbit QT-interval, action potential duration (APD), and membrane current were compared to those of E-4031, a recognized I(Kr) blocker. Measurements were made in rabbit Langendorff-perfused whole hearts, isolated papillary muscle, and single isolated ventricular myocytes. 2. Neither chromanol 293B (10 microM) nor L-735,821 (100 nM) had a significant effect on QTc interval in Langendorff-perfused hearts. E-4031 (100 nM), on the other hand, significantly increased QTc interval (35.6+/-3.9%, n=8, P<0.05). 3. Similarly both chromanol 293B (10 microM) and L-735,821 (100 nM) produced little increase in papillary muscle APD (less than 7%) while pacing at cycle lengths between 300 and 5000 ms. In contrast, E-4031 (100 nM) markedly increased (30 - 60%) APD in a reverse frequency-dependent manner. 4. In ventricular myocytes, the same concentrations of chromanol 293B (10 microM), L-735,821 (100 nM) and E-4031 (1 microM) markedly or totally blocked I(Ks) and I(Kr), respectively. 5. I(Ks) tail currents activated slowly (at +30 mV, tau=888.1+/-48.2 ms, n=21) and deactivated rapidly (at -40 mV, tau=157.1+/-4.7 ms, n=22), while I(Kr) tail currents activated rapidly (at +30 mV, tau=35.5+/-3.1 ms, n=26) and deactivated slowly (at -40 mV, tau(1)=641.5+/-29.0 ms, tau(2)=6531+/-343, n=35). I(Kr) was estimated to contribute substantially more to total current density during normal ventricular muscle action potentials (i.e., after a 150 ms square pulse to +30 mV) than does I(Ks). 6. These findings indicate that block of I(Ks) is not likely to provide antiarrhythmic benefit by lengthening normal ventricular muscle QTc, APD, and refractoriness over a wide range of frequencies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Benzodiazepines / pharmacology
  • Cell Separation
  • Chromans / pharmacology
  • Colforsin / pharmacology
  • Electrocardiography
  • Female
  • Heart / drug effects*
  • Heart / physiology
  • Heart Ventricles / drug effects
  • In Vitro Techniques
  • Kinetics
  • Long QT Syndrome / physiopathology
  • Male
  • Microelectrodes
  • Myocardium / cytology
  • Papillary Muscles / drug effects
  • Patch-Clamp Techniques
  • Piperidines / pharmacology
  • Potassium Channel Blockers*
  • Pyridines / pharmacology
  • Rabbits
  • Sulfonamides / pharmacology

Substances

  • Anti-Arrhythmia Agents
  • Chromans
  • L 735821
  • Piperidines
  • Potassium Channel Blockers
  • Pyridines
  • Sulfonamides
  • E 4031
  • Benzodiazepines
  • 6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane
  • Colforsin